0001819790-23-000062.txt : 20230626
0001819790-23-000062.hdr.sgml : 20230626
20230626181023
ACCESSION NUMBER: 0001819790-23-000062
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230622
FILED AS OF DATE: 20230626
DATE AS OF CHANGE: 20230626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Crane Rosemary A
CENTRAL INDEX KEY: 0001443343
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39614
FILM NUMBER: 231043547
MAIL ADDRESS:
STREET 1: C/O CATALENT, INC.
STREET 2: 14 SCHOOLHOUSE ROAD
CITY: SOMERSET
STATE: NJ
ZIP: 08873
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tarsus Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001819790
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 814717861
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15440 LAGUNA CANYON ROAD
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: (949) 409-9820
MAIL ADDRESS:
STREET 1: 15440 LAGUNA CANYON ROAD
CITY: IRVINE
STATE: CA
ZIP: 92618
4
1
wk-form4_1687817414.xml
FORM 4
X0407
4
2023-06-22
0
0001819790
Tarsus Pharmaceuticals, Inc.
TARS
0001443343
Crane Rosemary A
C/O TARSUS PHARMACEUTICALS, INC.
15440 LAGUNA CANYON ROAD, SUITE 160
IRVINE
CA
92618
1
0
0
0
0
Stock Option (right to buy)
17.99
2023-06-22
4
A
0
5000
0
A
2033-06-21
Common Stock
5000
5000
D
Restricted Stock Units
2023-06-22
4
A
0
3350
0
A
Common Stock
3350
3350
D
Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
/s/ Jeffrey Farrow, Attorney-in-Fact
2023-06-26